NARI - Inari Medical Inc
IEX Last Trade
43.225
-0.485 -1.122%
Share volume: 882,066
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$43.71
-0.49
-1.11%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-27 | 2023-05-03 | 2023-08-02 | 2023-11-01 | 2024-02-29 | 2024-04-30 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 487.819 M | 504.152 M | 506.534 M | 524.968 M | 548.835 M | 674.235 M | 661.776 M | 672.930 M | |
| Current Assets | 410.571 M | 422.905 M | 425.606 M | 444.617 M | 469.061 M | 235.563 M | 233.313 M | 249.352 M | |
| Inventories | 29.670 M | 32.581 M | 36.499 M | 38.984 M | 40.227 M | 42.900 M | 44.650 M | 49.359 M | |
| Other Current Assets | 7.609 M | 5.312 M | 4.942 M | 4.972 M | 7.944 M | 6.481 M | 8.240 M | 8.623 M | |
| Short Term Investments | 7.609 M | 5.312 M | 4.942 M | 4.972 M | 7.944 M | 6.481 M | 8.240 M | 8.623 M | |
| Total Receivables | 54.059 M | 58.611 M | 55.719 M | 63.128 M | 69.595 M | 70.119 M | 78.621 M | 81.631 M | |
| Current Cash | 319.233 M | 326.401 M | 328.446 M | 337.533 M | 351.295 M | 115.452 M | 101.302 M | 109.672 M | |
| Total Non-current Assets | 77.248 M | 81.247 M | 80.928 M | 80.351 M | 79.774 M | 438.672 M | 428.463 M | 423.578 M | |
| Property Plant Equipment | 21.191 M | 21.655 M | 21.245 M | 21.063 M | 21.243 M | 20.929 M | 20.761 M | 23.005 M | |
| Other Assets | 6.106 M | 8.889 M | 9.084 M | 9.431 M | 9.466 M | 4.117 M | 4.676 M | 4.242 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 150.884 M | 145.774 M | 143.106 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 214.335 M | 209.642 M | 204.401 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 487.819 M | 504.152 M | 506.534 M | 524.968 M | 548.835 M | 674.235 M | 661.776 M | 672.930 M | |
| Total liabilities | 72.720 M | 87.150 M | 79.798 M | 89.323 M | 96.693 M | 209.325 M | 214.546 M | 249.121 M | |
| Total current liabilities | 42.343 M | 56.174 M | 48.340 M | 58.238 M | 66.066 M | 76.339 M | 86.037 M | 138.261 M | |
| Accounts Payable | 6.035 M | 7.659 M | 7.352 M | 7.240 M | 10.091 M | 10.577 M | 12.026 M | 16.375 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 66.400 M | 63.341 M | 44.503 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 66.400 M | 63.341 M | 44.503 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 415.099 M | 417.002 M | 426.736 M | 435.645 M | 452.142 M | 464.910 M | 447.230 M | 423.809 M | |
| Common stock | 53.492 M | 53.721 M | 54.756 M | 57.208 M | 57.385 M | 57.734 M | 57.938 M | 58.142 M | |
| Retained earnings | -41.052 M | -46.850 M | -49.068 M | -46.983 M | -43.821 M | -48.486 M | -72.688 M | -104.036 M |